Crane Company (CR)
(Delayed Data from NYSE)
$157.47 USD
+0.19 (0.12%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $157.35 -0.12 (-0.08%) 7:58 PM ET
2-Buy of 5 2
D Value C Growth D Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$157.47 USD
+0.19 (0.12%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $157.35 -0.12 (-0.08%) 7:58 PM ET
2-Buy of 5 2
D Value C Growth D Momentum D VGM
Zacks News
General Electric (GE) Buys Prismatic Sensors, Wins Contracts
by Zacks Equity Research
Healthcare unit of General Electric (GE) acquires the developer of photon counting detectors, Prismatic Sensors, and introduces AI algorithm. GE Power receives two contracts.
Crane (CR) to Benefit From Buyouts and Growth Investments
by Zacks Equity Research
Crane (CR) stands to gain from the exposure in diverse end markets, acquired assets and cost reduction initiatives.
3M's (MMM) October Sales Increase Y/Y in Low-Single Digits
by Zacks Equity Research
3M's (MMM) sales performance in October is driven by gains from acquisitions/divestitures and healthy organic performance. Businesses in geographies flourish well.
5 Reasons Why Danaher (DHR) Stock is Worth Investing in Now
by Zacks Equity Research
Danaher (DHR) to benefit from healthy growth opportunities in Life Sciences and Diagnostics segments, acquired assets and shareholders-friendly policies.
ITT Q3 Earnings and Revenues Beat Estimates, Decline Y/Y
by Zacks Equity Research
ITT's third-quarter revenues decline 17% year over year on account of lackluster performance across its segments.
Honeywell (HON) Q3 Earnings & Revenues Top Estimates, Down Y/Y
by Zacks Equity Research
Honeywell (HON) third-quarter 2020 revenues decline 14% year over year on account of lackluster performance across most of its segments.
Should Value Investors Buy Crane (CR) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
3M (MMM) Q3 Earnings Beat Estimates, Fall Y/Y on High Costs
by Zacks Equity Research
3M's (MMM) third-quarter 2020 results reflect gains from higher sales generation as well as adverse impacts of higher costs and expenses, and taxes.
Crane (CR) Q3 Earnings & Revenues Surpass Estimates, Down Y/Y
by Zacks Equity Research
Crane's (CR) third-quarter 2020 revenues decline 4.9% year over year on lackluster performance across its segments, except Payment & Merchandising Technologies.
Crane (CR) Tops Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Crane (CR) delivered earnings and revenue surprises of 28.05% and 9.40%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Danaher (DHR) Q3 Earnings Beat, Rise Y/Y on Sales Growth
by Zacks Equity Research
Danaher's (DHR) Q3 results reflect growth in Life Sciences and Diagnostics segments' sales, contribution from Cytiva, and operating margin rise. Core Q4 sales are likely to grow in high-single digits.
Carlisle (CSL) Q3 Earnings Surpass Estimates, Revenues Miss
by Zacks Equity Research
Carlisle Companies' (CSL) third-quarter 2020 revenues decline 12% year over year on account of lackluster performance across its segments.
Earnings Preview: Crane (CR) Q3 Earnings Expected to Decline
by Zacks Equity Research
Crane (CR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Macquarie (MIC) Displays Bright Prospects, Risks Persist
by Zacks Equity Research
Macquarie (MIC) stands to gain from solid demand for storage of petroleum products, growth projects and shareholder-friendly policies. The coronavirus outbreak-led market downturn remains a concern.
Is Crane (CR) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
The Truth About Market Timing - September 29, 2020
by Zacks Equity Research
In the long-run, does consistent market timing really matter to be a successful investor?
Danaher (DHR) Gains 19% in 3 Months: What's Driving It?
by Zacks Equity Research
Danaher (DHR), with a 19% rise in the past three months, benefits from core sales growth opportunities in Diagnostics and Life Sciences segments, innovation efforts, and shareholder-friendly policies.
The Keys to Successfully Timing the Markets - September 03, 2020
by Zacks Equity Research
In the long-run, does consistent market timing really matter to be a successful investor?
Crane (CR) Up 1.3% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Crane (CR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Crane (CR) Up 1.3% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Crane (CR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Crane to Benefit From Acquisitions Amid Pandemic Scares
by Zacks Equity Research
Crane (CR) is likely to benefit from the exposure in diverse end-markets, acquired assets and repositioning initiatives. However, the coronavirus outbreak-led market downturn remains concerning.
Yes, You Can Time the Market. Find out How - August 12, 2020
by Zacks Equity Research
Have you ever dreamed of being that one in a million investor who has the talent to perfectly time the markets?
3M (MMM) Q2 Earnings Surpass Earnings, Fall Y/Y on Weak Sales
by Zacks Equity Research
3M's (MMM) second-quarter 2020 results reflect the adverse impacts of the coronavirus outbreak, forex woes and inorganic actions, offset by lower taxes, a fall in share count and cost reduction.
Crane (CR) Q2 Earnings and Revenues Beat Estimates, Down Y/Y
by Zacks Equity Research
Crane's (CR) second-quarter 2020 revenues decline 19.5% year over year on lackluster performance across its segments.
Crane (CR) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Crane (CR) delivered earnings and revenue surprises of 36.17% and 10.79%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?